N-oxides of venlafaxine and Odesmethylvenlafaxine as prodrugs

Details for Australian Patent Application No. 2008267273 (hide)

Owner Solvay Pharmaceuticals B.V.

Inventors Vader, Sander; Tulp, Martinus; Kruse, Cornelis G.; Stoit, Axel; Turski, Lechoslaw A.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008267273

PCT Pub. Number WO2009/000797

Priority 07111028.2 26.06.07 EP; 60/946,200 26.06.07 US

Filing date 23 June 2008

Wipo publication date 31 December 2008

International Classifications

C07C 291/04 (2006.01) Compounds containing carbon and nitrogen and having functional groups not covered by groups

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

Event Publications

28 January 2010 PCT application entered the National Phase

  PCT publication WO2009/000797 Priority application(s): WO2009/000797

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008267274-Sildenafil N-oxide as prodrug

2008267262-Dispensing means with lockable dose adjuster and one way valve